BIOTECHNICA 2008 Boasts Debut of New Event for Pharmaceutical Biotechnology
BIOTECHNICA 2008 will be staging the first separate meeting-place
for pharmaceutical biotechnology. This year´s event will see the debut
of the new platform "Science to Market" staged by the European
Association of Pharma Biotechnology (EAPB), which represents joint
cooperation with European BioPerspectives, a conference organized by
DECHEMA (Society for Chemical Engineering and Biotechnology). Stephan
Kuhne, Board member of Deutsche Messe AG, believes: "The collaboration
with BIOTECHNICA will add considerably to the promotion of research
projects dedicated to pharmaceutical biotechnology." The President of
the EAPB, Wieland Wolf, adds: "Science to Market will provide an
important impetus to the dialogue between science and the business
community. The event offers European research institutes and
universities an ideal platform for presenting their R&D efforts and an
opportunity to establish international contacts with industrial
companies with a view to promoting potentially commercial products."
Wieland Wolf explains: "Pharmaceutical biotechnology is becoming
an important economic factor worldwide. In 2006 innovative
developments in the therapy, diagnosis and prevention of disease
produced global sales worth 60 billion US dollars. Across the entire
industry we are seeing annual growth rates of up to twenty percent."
Therefore the aim of the new platform "Science to Market" is to
promote and underpin the scientific and research side of European
pharmaceutical biotechnology.
"Science to Market" will take place on 7 and 8 October in the
Convention Center at the Hannover Exhibition Grounds. The focus of the
two-day conference will be on the application of new biopharmaceutical
drugs and developments in diagnosis as well as the current technology
in biopharmaceutical development and manufacture. Keynote themes
include second-generation biopharmaceuticals, new types of vaccine
developments in gene therapy, drug formats and methods for improving
the production and analysis of modern biopharmaceuticals.
For more details on the events and conference program please
visit: www.eapb.org.
Additional press releases and photos may be downloaded from:
www.biotechnica.de/pressservice